Cholecalciferol Background

Cholecalciferol, also known as vitamin D3, is a secosteroid molecule with one open ring that can be synthesized by the human body during UVB radiation exposure [1][5].

The compound was discovered as one of five forms of vitamin D, with a unique mechanism of activation involving two hydroxylation processes in the liver and kidney [1].

A 293 nanometer UVB light-emitting diode (LED) was found to be 2.4 times more efficient in producing vitamin D3 than sunlight in less than 1/60 the time [1].

Interestingly, cholecalciferol challenges the traditional vitamin definition, as it can be synthesized by the body, unlike classic vitamins that must be ingested [1].

Cholecalciferol Systemic Applications

Cholecalciferol demonstrates versatility in systemic applications, addressing vitamin D insufficiency and offering potential benefits across multiple health domains [6].

It is indicated for patients with vitamin D deficiency and has been associated with reducing risks of cardiovascular disease, type 2 diabetes, cancer, depression, and cognitive impairment [6].

Off-label uses include preventing bone loss, treating osteoporosis, preventing falls in older adults, and potentially mitigating various health conditions [6].

The compound appears to stimulate the body's interferon type I signaling system, providing protection against bacteria and viruses [1].

Cholecalciferol for Brain and Cognition

Research suggests vitamin D can exert neurocognitive effects through mechanisms including neuroprotection, oxidative stress modulation, and neurological regulation [3].

A study found that vitamin D3 supplementation (2000 IU/day) may provide modest cognitive benefits, particularly among older Black adults [7].

Both cholecalciferol and 25-hydroxyvitamin D can pass the blood-brain barrier, though direct neuronal function impact remains under investigation [3].

The compound's potential cognitive benefits continue to be an active area of scientific research and exploration [3].

Cholecalciferol for Eye and Vision

Vitamin D3 plays a vital role in eye health, demonstrating effectiveness in altering inflammatory and retinal damage mediators [9].

Topical application of 1,25-(OH)2D3 in animal models with dry eye reduced corneal inflammation and improved clinical signs [4][8].

Calcitriol has been shown to inhibit hyperosmotic stress-induced cellular inflammation in human corneal epithelial cells and modify toll-like receptor-mediated inflammation [4][8].

Research suggests potential benefits in diabetes control and prevention of diabetic retinopathy, though causal links remain under investigation [9].

Relevant quotes:

"Vitamin D insufficiency and deficiency are prevalent worldwide" - StatPearls [6]

Relevant NCBI article quotes:

"Vitamin D can exert its effect on neurocognition through a number of mechanisms such as induction of neuroprotection, modulation of oxidative stress" - Role of Vitamin D in Cognitive Dysfunction [3]

Functions supported or stimulated:

1. Interferon type I signaling

2. Calcium and phosphate homeostasis

3. Bone metabolism

4. Immune system regulation

5. Neuroprotection

Related benefits:

1. Reduced cardiovascular disease risk

2. Potential cognitive function support

3. Bone health maintenance

4. Immune system enhancement

5. Potential eye health improvement

Suggested daily human dosage ranges:

2000 IU/day cholecalciferol [7]

Source Information:

Cholecalciferol is synthesized in human skin from 7-dehydrocholesterol under UV light exposure [2]

Citations:

[1] https://en.wikipedia.org/wiki/Cholecalciferol

[2] https://pmc.ncbi.nlm.nih.gov/articles/PMC3968073/

[3] https://pmc.ncbi.nlm.nih.gov/articles/PMC8620681/

[4] https://journals.lww.com/ijo/fulltext/2023/04000/vitamin_d_and_eye__current_evidence_and_practice.16.aspx

[5] https://en.wikipedia.org/wiki/Vitamin_D_supplement?ms=FITwitter

[6] https://www.ncbi.nlm.nih.gov/books/NBK549768/

[7] https://www.nature.com/articles/s41598-021-02485-8

[8] https://pmc.ncbi.nlm.nih.gov/articles/PMC10276688/

[9] https://www.mdpi.com/2072-6643/16/12/1878